Prof. Dr. Peter-Bram ’t Hoen began his tenure as Professor of Bioinformatics at Radboud University Medical Center in February 2018. During his postdoctoral research at Leiden University Medical Center, he employed advanced molecular techniques to identify biomarkers for evaluating the effects of potential new therapies for Duchenne muscular dystrophy. These innovative -omics approaches generate vast amounts of data, prompting ’t Hoen to specialize in bioinformatics and data analysis.

At Radboudumc, he focuses on developing new, personalized treatments for patients. He leads the international ReCognitION consortium, which aims to identify biomarkers and novel drug targets for myotonic dystrophy. Prof. ’t Hoen is also an active member of the research working group of the European Reference Network on Neuromuscular Diseases (EURO-NMD) and is involved in developing a EURO-NMD registry for patients with neuromuscular diseases.

A strong advocate for empowering individuals to manage and share their health data with chosen parties, he is part of the management team of the Personal Health Train coalition, which strives to achieve this vision.